Index by author

01 March 2003; volume 21, issue 3

A

  1. Adams, L.

    1. Browne, H.A.K. et al "Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response." European Respiratory Journal 21.3 (2003): 523-529. Web. 29 Feb. 2020.

  2. Ambrosino, N.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.
    2. Clini, E., and N. Ambrosino. "From the Authors." European Respiratory Journal 21.3 (2003): 558-559. Web. 29 Feb. 2020.

  3. Andersen, A.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

  4. Annesi Maesano, I.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  5. Antony, V.B.

    1. Antony, V.B.. "Immunological mechanisms in pleural disease." European Respiratory Journal 21.3 (2003): 539-544. Web. 29 Feb. 2020.

  6. Asher, M.I.

    1. Crane, J. et al "Agreement between written and video questions for comparing asthma symptoms in ISAAC." European Respiratory Journal 21.3 (2003): 455-461. Web. 29 Feb. 2020.

  7. Åström, J.

    1. Sabounchi-Schütt, F. et al "Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach." European Respiratory Journal 21.3 (2003): 414-420. Web. 29 Feb. 2020.

B

  1. Bach, J.R.

    1. Bach, J.R.. "Mechanical insufflation/exsufflation: has it come of age? A commentary." European Respiratory Journal 21.3 (2003): 385-386. Web. 29 Feb. 2020.

  2. Bachl, C.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  3. Bakke, P.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

  4. Baldi, I.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  5. Barnes, P.J.

    1. Kharitonov, S.A. et al "Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children." European Respiratory Journal 21.3 (2003): 433-438. Web. 29 Feb. 2020.
    2. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  6. Beasley, R.

    1. Crane, J. et al "Agreement between written and video questions for comparing asthma symptoms in ISAAC." European Respiratory Journal 21.3 (2003): 455-461. Web. 29 Feb. 2020.

  7. Beccaria, M.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  8. Bestry, I.

    1. Radzikowska, E. et al "Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer." European Respiratory Journal 21.3 (2003): 552-555. Web. 29 Feb. 2020.

  9. Blesa, S.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  10. Bononi, I.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  11. Bonsignore, G.

    1. Marrone, O. et al "Blood pressure responsiveness to obstructive events during sleep after chronic CPAP." European Respiratory Journal 21.3 (2003): 509-514. Web. 29 Feb. 2020.

  12. Bonsignore, M.R.

    1. Marrone, O. et al "Blood pressure responsiveness to obstructive events during sleep after chronic CPAP." European Respiratory Journal 21.3 (2003): 509-514. Web. 29 Feb. 2020.

  13. Boschetto, P.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  14. Braccioni, F.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  15. Britton, S.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  16. Brogger, J.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

  17. Browne, H.A.K.

    1. Browne, H.A.K. et al "Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response." European Respiratory Journal 21.3 (2003): 523-529. Web. 29 Feb. 2020.

  18. Bulpa, P.A.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

C

  1. Calverley, P.M.A.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.

  2. Cantagrel, A.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  3. Caramori, G.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  4. Cerveri, I.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  5. Chabowski, M.

    1. Radzikowska, E. et al "Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer." European Respiratory Journal 21.3 (2003): 552-555. Web. 29 Feb. 2020.

  6. Chan, S.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  7. Charpin, D.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  8. Chatwin, M.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.

  9. Chilcott, J.

    1. Mar, J. et al "The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea." European Respiratory Journal 21.3 (2003): 515-522. Web. 29 Feb. 2020.

  10. Ciaccia, A.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  11. Clini, E.

    1. Clini, E., and N. Ambrosino. "From the Authors." European Respiratory Journal 21.3 (2003): 558-559. Web. 29 Feb. 2020.

  12. Closa, D.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  13. Connolly, C.K.

    1. Connolly, C.K.. "Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed?." European Respiratory Journal 21.3 (2003): 556-557. Web. 29 Feb. 2020.

  14. Constantopoulos, S.

    1. Tsangaris, I. et al "Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury." European Respiratory Journal 21.3 (2003): 495-501. Web. 29 Feb. 2020.

  15. Cortijo, J.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  16. Cramer, D.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  17. Crane, J.

    1. Crane, J. et al "Agreement between written and video questions for comparing asthma symptoms in ISAAC." European Respiratory Journal 21.3 (2003): 455-461. Web. 29 Feb. 2020.

D

  1. Dal Corso, S.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  2. Decramer, M.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.

  3. De Fuccio, M.B.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  4. Delcroix, M.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  5. Delos, M.A.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  6. Demedts, M.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  7. De Rosa, E.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  8. Dive, A.M.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  9. Dupont, L.J.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  10. Durán-Cantolla, J.

    1. Mar, J. et al "The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea." European Respiratory Journal 21.3 (2003): 515-522. Web. 29 Feb. 2020.

E

  1. Eide, G.E.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

  2. Eklund, A.

    1. Sabounchi-Schütt, F. et al "Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach." European Respiratory Journal 21.3 (2003): 414-420. Web. 29 Feb. 2020.

  3. Elias, D.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  4. Estrela, J.M.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  5. Evrard, P.A.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

F

  1. Fabbri, L.M.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  2. Fehrenbach, H.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

  3. Ferrarotti, I.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  4. Filleul, L.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  5. Fuld, J.P.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

G

  1. Gainnier, M.

    1. Papazian, L., and M. Gainnier. "Indications of BAL, lung biopsy, or both in mechanically ventilated patients with unexplained infiltrations." European Respiratory Journal 21.3 (2003): 383-384. Web. 29 Feb. 2020.

  2. Gilè, L.S.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  3. Goldmann, T.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

  4. Gonio, F.

    1. Kharitonov, S.A. et al "Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children." European Respiratory Journal 21.3 (2003): 433-438. Web. 29 Feb. 2020.

  5. Gonzalez, M.R.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  6. Grunewald, J.

    1. Sabounchi-Schütt, F. et al "Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach." European Respiratory Journal 21.3 (2003): 414-420. Web. 29 Feb. 2020.

  7. Gulsvik, A.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

H

  1. Hart, N.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.

  2. Hellman, U.

    1. Sabounchi-Schütt, F. et al "Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach." European Respiratory Journal 21.3 (2003): 414-420. Web. 29 Feb. 2020.

  3. Ho, J.C.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  4. Ho, P.L.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  5. Hytönen, A.M.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

I

  1. Insalaco, G.

    1. Marrone, O. et al "Blood pressure responsiveness to obstructive events during sleep after chronic CPAP." European Respiratory Journal 21.3 (2003): 509-514. Web. 29 Feb. 2020.

  2. Ip, M.S.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

J

  1. Jamart, J.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  2. Jarvis, D.

    1. Knox, J., D. Jarvis, and . "The European Community Respiratory Health Survey II." European Respiratory Journal 21.3 (2003): 556-560. Web. 29 Feb. 2020.

  3. Johansen, B.

    1. Brogger, J. et al "Long-term changes in adult asthma prevalence." European Respiratory Journal 21.3 (2003): 468-472. Web. 29 Feb. 2020.

K

  1. Kaneko, T.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  2. Kelly, C.

    1. Kharitonov, S.A. et al "Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children." European Respiratory Journal 21.3 (2003): 433-438. Web. 29 Feb. 2020.

  3. Kharitonov, S.A.

    1. Kharitonov, S.A. et al "Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children." European Respiratory Journal 21.3 (2003): 433-438. Web. 29 Feb. 2020.
    2. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  4. Kiss, D.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  5. Kitsiouli, E.

    1. Tsangaris, I. et al "Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury." European Respiratory Journal 21.3 (2003): 495-501. Web. 29 Feb. 2020.

  6. Knox, J.

    1. Knox, J., D. Jarvis, and . "The European Community Respiratory Health Survey II." European Respiratory Journal 21.3 (2003): 556-560. Web. 29 Feb. 2020.

  7. Köhnlein, T.

    1. Köhnlein, T., and T. Welte. "Noninvasive ventilation in stable chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 558. Web. 29 Feb. 2020.

L

  1. Laan, M.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  2. Lam, W.K.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  3. Lekka, M.E.

    1. Tsangaris, I. et al "Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury." European Respiratory Journal 21.3 (2003): 495-501. Web. 29 Feb. 2020.

  4. Lerut, T.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  5. Leung, R.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  6. Lindén, A.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  7. lnstallé, E.J.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  8. Lötvall, J.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  9. Luisetti, M.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

M

  1. Mabeza, G.F.

    1. Mabeza, G.F., and J. Macfarlane. "Pulmonary actinomycosis." European Respiratory Journal 21.3 (2003): 545-551. Web. 29 Feb. 2020.

  2. Macfarlane, J.

    1. Mabeza, G.F., and J. Macfarlane. "Pulmonary actinomycosis." European Respiratory Journal 21.3 (2003): 545-551. Web. 29 Feb. 2020.

  3. Malaguti, C.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  4. Mallol, J.

    1. Crane, J. et al "Agreement between written and video questions for comparing asthma symptoms in ISAAC." European Respiratory Journal 21.3 (2003): 455-461. Web. 29 Feb. 2020.

  5. Mapp, C.E.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  6. Mar, J.

    1. Mar, J. et al "The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea." European Respiratory Journal 21.3 (2003): 515-522. Web. 29 Feb. 2020.

  7. Marchand, E.

    1. Marchand, E.. "Survival in COPD patients after regular use of fluticasone propionate and salmeterol." European Respiratory Journal 21.3 (2003): 559-560. Web. 29 Feb. 2020.

  8. Marrone, O.

    1. Marrone, O. et al "Blood pressure responsiveness to obstructive events during sleep after chronic CPAP." European Respiratory Journal 21.3 (2003): 509-514. Web. 29 Feb. 2020.

  9. Mata, M.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  10. Meah, S.

    1. Kharitonov, S.A. et al "Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children." European Respiratory Journal 21.3 (2003): 433-438. Web. 29 Feb. 2020.

  11. Melese, E.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  12. Mertens, L.

    1. Bulpa, P.A. et al "Combined bronchoalveolar lavage and transbronchial lung biopsy: safety and yield in ventilated patients." European Respiratory Journal 21.3 (2003): 489-494. Web. 29 Feb. 2020.

  13. Miniati, M.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  14. Miotto, D.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  15. Miyamoto, M.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  16. Moges, F.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  17. Morcillo, E.J.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  18. Morrell, M.J.

    1. Browne, H.A.K. et al "Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response." European Respiratory Journal 21.3 (2003): 523-529. Web. 29 Feb. 2020.

  19. Müller-Quernheim, J.

    1. Ziegenhagen, M.W. et al "Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis." European Respiratory Journal 21.3 (2003): 407-413. Web. 29 Feb. 2020.
    2. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

N

  1. Nakos, G.

    1. Tsangaris, I. et al "Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury." European Respiratory Journal 21.3 (2003): 495-501. Web. 29 Feb. 2020.

  2. Neder, J.A.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  3. Nery, L.E.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  4. Neukirch, F.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  5. Ng, P.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  6. Nickol, A.H.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.

P

  1. Pabst, R.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

  2. Papazian, L.

    1. Papazian, L., and M. Gainnier. "Indications of BAL, lung biopsy, or both in mechanically ventilated patients with unexplained infiltrations." European Respiratory Journal 21.3 (2003): 383-384. Web. 29 Feb. 2020.

  3. Papi, A.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.
    2. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  4. Paredi, P.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  5. Pignatti, P.F.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  6. Polkey, M.I.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.

  7. Porta, R.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  8. Pozzi, E.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.

  9. Prause, O.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  10. Pride, N.B.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.
    2. Soriano, J.B., J. Vestbo, and N.B. Pride. "From the Authors." European Respiratory Journal 21.3 (2003): 560. Web. 29 Feb. 2020.

R

  1. Radzikowska, E.

    1. Radzikowska, E. et al "Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer." European Respiratory Journal 21.3 (2003): 552-555. Web. 29 Feb. 2020.

  2. Reis, S.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  3. Rennard, S.I.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.

  4. Ross, E.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.

  5. Rothe, M.E.

    1. Ziegenhagen, M.W. et al "Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis." European Respiratory Journal 21.3 (2003): 407-413. Web. 29 Feb. 2020.

  6. Rueda, J.R.

    1. Mar, J. et al "The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea." European Respiratory Journal 21.3 (2003): 515-522. Web. 29 Feb. 2020.

S

  1. Sabounchi-Schütt, F.

    1. Sabounchi-Schütt, F. et al "Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach." European Respiratory Journal 21.3 (2003): 414-420. Web. 29 Feb. 2020.

  2. Saetta, M.

    1. Boschetto, P. et al "Predominant emphysema phenotype in chronic obstructive pulmonary disease patients." European Respiratory Journal 21.3 (2003): 450-454. Web. 29 Feb. 2020.

  3. Salvaggio, A.

    1. Marrone, O. et al "Blood pressure responsiveness to obstructive events during sleep after chronic CPAP." European Respiratory Journal 21.3 (2003): 509-514. Web. 29 Feb. 2020.

  4. Santangelo, F.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  5. Schechter, C.

    1. Mar, J. et al "The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea." European Respiratory Journal 21.3 (2003): 515-522. Web. 29 Feb. 2020.

  6. Schlaak, M.

    1. Ziegenhagen, M.W. et al "Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis." European Respiratory Journal 21.3 (2003): 407-413. Web. 29 Feb. 2020.

  7. Schmidt, H.

    1. Neder, J.A. et al "The pattern and timing of breathing during incremental exercise: a normative study." European Respiratory Journal 21.3 (2003): 530-538. Web. 29 Feb. 2020.

  8. Schön, T.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  9. Schragel, D.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  10. Serrano, A.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  11. Sertl, K.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  12. Simonds, A.K.

    1. Chatwin, M. et al "Cough augmentation with mechanical insufflation/exsufflation in patients with neuromuscular weakness." European Respiratory Journal 21.3 (2003): 502-508. Web. 29 Feb. 2020.
    2. Browne, H.A.K. et al "Ageing does not influence the sleep-related decrease in the hypercapnic ventilatory response." European Respiratory Journal 21.3 (2003): 523-529. Web. 29 Feb. 2020.

  13. Sjöstrand, M.

    1. Laan, M. et al "A role of GM-CSF in the accumulation of neutrophils in the airways caused by IL-17 and TNF‐α." European Respiratory Journal 21.3 (2003): 387-393. Web. 29 Feb. 2020.

  14. Soriano, J.B.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.
    2. Soriano, J.B., J. Vestbo, and N.B. Pride. "From the Authors." European Respiratory Journal 21.3 (2003): 560. Web. 29 Feb. 2020.

  15. Stendahl, O.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  16. Stewart, A.

    1. Crane, J. et al "Agreement between written and video questions for comparing asthma symptoms in ISAAC." European Respiratory Journal 21.3 (2003): 455-461. Web. 29 Feb. 2020.

  17. Stöllberger, C.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  18. Suchankova, J.

    1. Blesa, S. et al "Oral N‐acetylcysteine attenuates the rat pulmonary inflammatory response to antigen." European Respiratory Journal 21.3 (2003): 394-400. Web. 29 Feb. 2020.

  19. Sun, J.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  20. Sundqvist, T.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  21. Szczepulska, E.

    1. Radzikowska, E. et al "Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer." European Respiratory Journal 21.3 (2003): 552-555. Web. 29 Feb. 2020.

T

  1. Tessema, T.

    1. Schön, T. et al "Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis." European Respiratory Journal 21.3 (2003): 483-488. Web. 29 Feb. 2020.

  2. Tessier, J.F.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  3. Tipoe, G.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  4. Tsang, K.W.

    1. Tsang, K.W. et al "Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro." European Respiratory Journal 21.3 (2003): 401-406. Web. 29 Feb. 2020.

  5. Tsangaris, I.

    1. Tsangaris, I. et al "Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury." European Respiratory Journal 21.3 (2003): 495-501. Web. 29 Feb. 2020.

  6. Tschernig, T.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

V

  1. Vandentorren, S.

    1. Vandentorren, S. et al "Long-term mortality among adults with or without asthma in the PAARC study." European Respiratory Journal 21.3 (2003): 462-467. Web. 29 Feb. 2020.

  2. Vanhaecke, J.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  3. Van Raemdonck, D.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  4. Veegh, W.

    1. Kiss, D. et al "Bronchial asthma causing symptoms suggestive of angina pectoris." European Respiratory Journal 21.3 (2003): 473-477. Web. 29 Feb. 2020.

  5. Verleden, G.M.

    1. Verleden, G.M. et al "Exhaled nitric oxide after lung transplantation: impact of the native lung." European Respiratory Journal 21.3 (2003): 429-432. Web. 29 Feb. 2020.

  6. Vermeire, P.A.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.

  7. Vestbo, J.

    1. Rennard, S.I. et al "From the Authors." European Respiratory Journal 21.3 (2003): 557. Web. 29 Feb. 2020.
    2. Soriano, J.B., J. Vestbo, and N.B. Pride. "From the Authors." European Respiratory Journal 21.3 (2003): 560. Web. 29 Feb. 2020.

  8. Vollmer, E.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

W

  1. Walters, E.H.

    1. Walters, E.H.. "From the Authors." European Respiratory Journal 21.3 (2003): 556. Web. 29 Feb. 2020.

  2. Ward, S.

    1. Paredi, P. et al "Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 439-443. Web. 29 Feb. 2020.

  3. Welte, T.

    1. Köhnlein, T., and T. Welte. "Noninvasive ventilation in stable chronic obstructive pulmonary disease." European Respiratory Journal 21.3 (2003): 558. Web. 29 Feb. 2020.

Z

  1. Ziegenhagen, M.W.

    1. Ziegenhagen, M.W. et al "Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis." European Respiratory Journal 21.3 (2003): 407-413. Web. 29 Feb. 2020.

  2. Zissel, G.

    1. Fehrenbach, H. et al "Alveolar macrophages are the main source for tumour necrosis factor‐α in patients with sarcoidosis." European Respiratory Journal 21.3 (2003): 421-428. Web. 29 Feb. 2020.

  3. Zorzetto, M.

    1. Ferrarotti, I. et al "Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema." European Respiratory Journal 21.3 (2003): 444-449. Web. 29 Feb. 2020.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts